Here are five insights:
1. A total of 965 IBD patients — 61.9 percent suffered from Crohn’s disease and 38.1 percent from ulcerative colitis — formed the study population
2. Researchers included IBD patients with up to five-year follow-up from a longitudinal IBD natural history registry in the study.
2. Among the 965 IBD patients, 29.9 percent had low mean vitamin D levels.
3. Over the five-year study period, subjects with low mean vitamin D required significantly more steroids, biologics, narcotics, computed tomography scans, emergency department visits, hospital admissions and surgery compared with patients who had normal mean vitamin D levels.
4. Subjects with low vitamin D levels had worse pain, disease activity scores and quality of life.
5. Patients who received vitamin D supplements had a significant reduction in their healthcare utilization rates.
More articles on GI/endoscopy:
Crohn’s & Colitis Foundation of American honors Dr. Paul Lebovitz: 5 key notes
GI physician leader to know: Dr. Max Shapiro of Metro Atlanta Gastroenterology
Exalenz Bioscience collaborates with Acute Liver Failure Study Group, EndoChoice CFO buys 5k shares & more – 4 GI company key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
